Average Insider

Where insiders trade, we follow

Insider Buy/Sell Ratio for January 2026

Extreme outlier transactions (>3ฯƒ) are excluded.Show All Data
Ratio0.2:1
Daily Buy & Sell Volume

By Sector

By Industry

MediaAlpha, Inc. (MAX)

Yi Steven โ€” Director
Jan 12, 2026
Sale
Shares
8,000
Price
$11.51
Total Value
$92.08K
Shares Held After
2,799,330
% of Holdings
0.3%

MediaAlpha, Inc. (MAX)

Nonko Eugene โ€” Director
Jan 12, 2026
Sale
Shares
6,700
Price
$11.52
Total Value
$77.20K
Shares Held After
1,536,020
% of Holdings
0.4%

MediaAlpha, Inc. (MAX)

Nonko Eugene โ€” Director
Jan 12, 2026
Sale
Shares
5,400
Price
$11.52
Total Value
$62.18K
Shares Held After
992,848
% of Holdings
0.5%

Movano Inc. (MOVE)

Leabman Michael Aaron โ€” Director
Jan 12, 2026
Sale
Shares
3,377
Price
$7.01
Total Value
$23.67K
Shares Held After
31,560
% of Holdings
9.7%

Omeros Corporation (OMER)

Borges David J. โ€” VP, Finance & CAO
Jan 12, 2026
Sale
Shares
30,000
Price
$12.72
Total Value
$381.60K
Shares Held After
0
% of Holdings
100.0%

Verastem, Inc. (VSTM)

Paterson Dan โ€” Director
Jan 12, 2026
Sale
Shares
10,321
Price
$7.16
Total Value
$73.90K
Shares Held After
400,104
% of Holdings
2.5%

Verastem, Inc. (VSTM)

Calkins Daniel โ€” Chief Financial Officer
Jan 12, 2026
Sale
Shares
5,039
Price
$7.16
Total Value
$36.08K
Shares Held After
104,719
% of Holdings
4.6%

Seagate Technology Holdings plc (STX)

Teh Ban Seng โ€” EVP & Chief Commercial Officer
Jan 12, 2026
Sale
Shares
1,412
Price
$299.31
Total Value
$422.63K
Shares Held After
13,693
% of Holdings
9.3%

GREIF, INC (GEF, GEF-B)

Bergwall Timothy โ€” SVP, Chief Commercial Officer
Jan 12, 2026
Sale
Shares
2,000
Price
$71.54
Total Value
$143.07K
Shares Held After
58,678
% of Holdings
3.3%

Argan, Inc. (AGX)

Leimkuhler William F. โ€” Director
Jan 12, 2026
Sale
Shares
2,164
Price
$318.28
Total Value
$688.76K
Shares Held After
65,195
% of Holdings
3.2%

EverQuote, Inc. (EVER)

Neble George R โ€” Director
Jan 12, 2026
Sale
Shares
671
Price
$25.73
Total Value
$17.26K
Shares Held After
52,161
% of Holdings
1.3%

EverQuote, Inc. (EVER)

Shields John L. โ€” Director
Jan 12, 2026
Sale
Shares
2,000
Price
$25.73
Total Value
$51.46K
Shares Held After
25,219
% of Holdings
7.3%
Jan 12, 2026
Sale
Shares
1,928
Price
$76.69
Total Value
$147.86K
Shares Held After
6,841,606
% of Holdings
0.0%
Jan 12, 2026
Sale
Shares
16,065
Price
$76.20
Total Value
$1.22M
Shares Held After
6,843,534
% of Holdings
0.2%
Jan 12, 2026
Sale
Shares
200,000
Price
$4.71
Total Value
$942.00K
Shares Held After
1,006,439
% of Holdings
16.6%

Plug Power Inc. (PLUG)

Haycraft Benjamin โ€” CSO & GM EMEA
Jan 12, 2026
Sale
Shares
40,000
Price
$2.17
Total Value
$86.80K
Shares Held After
333,809
% of Holdings
10.7%

Alignment Healthcare, Inc. (ALHC)

KAO JOHN E โ€” Director
Jan 12, 2026
Sale
Shares
2,727
Price
$21.57
Total Value
$58.81K
Shares Held After
2,832,641
% of Holdings
0.1%

Alignment Healthcare, Inc. (ALHC)

KAO JOHN E โ€” Director
Jan 12, 2026
Sale
Shares
177,273
Price
$21.10
Total Value
$3.74M
Shares Held After
2,835,368
% of Holdings
5.9%
Jan 12, 2026
Sale
Shares
10,000
Price
$38.54
Total Value
$385.40K
Shares Held After
200,859
% of Holdings
4.7%

uniQure N.V. (QURE)

Gut Robert โ€” Director
Jan 12, 2026
Sale
Shares
7,803
Price
$25.09
Total Value
$195.78K
Shares Held After
32,342
% of Holdings
19.4%

uniQure N.V. (QURE)

Gut Robert โ€” Director
Jan 12, 2026
Sale
Shares
500
Price
$25.03
Total Value
$12.52K
Shares Held After
40,145
% of Holdings
1.2%

uniQure N.V. (QURE)

Gut Robert โ€” Director
Jan 12, 2026
Sale
Shares
17,310
Price
$24.39
Total Value
$422.19K
Shares Held After
40,645
% of Holdings
29.9%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Jan 12, 2026
Sale
Shares
15
Price
$377.82
Total Value
$5.67K
Shares Held After
22,511
% of Holdings
0.1%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Jan 12, 2026
Sale
Shares
19
Price
$375.65
Total Value
$7.14K
Shares Held After
22,526
% of Holdings
0.1%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Jan 12, 2026
Sale
Shares
14
Price
$374.44
Total Value
$5.24K
Shares Held After
22,545
% of Holdings
0.1%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Jan 12, 2026
Sale
Shares
3
Price
$372.46
Total Value
$1.12K
Shares Held After
22,559
% of Holdings
0.0%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Jan 12, 2026
Sale
Shares
18
Price
$370.87
Total Value
$6.68K
Shares Held After
22,562
% of Holdings
0.1%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Jan 12, 2026
Sale
Shares
40
Price
$369.48
Total Value
$14.78K
Shares Held After
22,580
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Jan 12, 2026
Sale
Shares
92
Price
$368.62
Total Value
$33.91K
Shares Held After
22,620
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Jan 12, 2026
Sale
Shares
41
Price
$367.40
Total Value
$15.06K
Shares Held After
22,712
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Jan 12, 2026
Sale
Shares
50
Price
$366.41
Total Value
$18.32K
Shares Held After
22,753
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Jan 12, 2026
Sale
Shares
220
Price
$365.56
Total Value
$80.42K
Shares Held After
22,803
% of Holdings
1.0%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Jan 12, 2026
Sale
Shares
199
Price
$364.83
Total Value
$72.60K
Shares Held After
23,023
% of Holdings
0.9%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Jan 12, 2026
Sale
Shares
47
Price
$363.55
Total Value
$17.09K
Shares Held After
23,222
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Jan 12, 2026
Sale
Shares
73
Price
$362.38
Total Value
$26.45K
Shares Held After
23,269
% of Holdings
0.3%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Jan 12, 2026
Sale
Shares
98
Price
$361.45
Total Value
$35.42K
Shares Held After
23,342
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Jan 12, 2026
Sale
Shares
155
Price
$360.22
Total Value
$55.83K
Shares Held After
23,440
% of Holdings
0.7%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Jan 12, 2026
Sale
Shares
85
Price
$359.14
Total Value
$30.53K
Shares Held After
23,595
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Jan 12, 2026
Sale
Shares
123
Price
$358.18
Total Value
$44.06K
Shares Held After
23,680
% of Holdings
0.5%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Jan 12, 2026
Sale
Shares
96
Price
$357.17
Total Value
$34.29K
Shares Held After
23,803
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Jan 12, 2026
Sale
Shares
41
Price
$356.09
Total Value
$14.60K
Shares Held After
23,899
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Jan 12, 2026
Sale
Shares
42
Price
$355.16
Total Value
$14.92K
Shares Held After
23,940
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Jan 12, 2026
Sale
Shares
39
Price
$353.95
Total Value
$13.80K
Shares Held After
23,982
% of Holdings
0.2%
Jan 12, 2026
Sale
Shares
94
Price
$377.82
Total Value
$35.52K
Shares Held After
78,411
% of Holdings
0.1%
Jan 12, 2026
Sale
Shares
118
Price
$375.65
Total Value
$44.33K
Shares Held After
78,505
% of Holdings
0.2%
Jan 12, 2026
Sale
Shares
88
Price
$374.44
Total Value
$32.95K
Shares Held After
78,623
% of Holdings
0.1%
Jan 12, 2026
Sale
Shares
21
Price
$372.46
Total Value
$7.82K
Shares Held After
78,711
% of Holdings
0.0%
Jan 12, 2026
Sale
Shares
118
Price
$370.87
Total Value
$43.76K
Shares Held After
78,732
% of Holdings
0.1%
Jan 12, 2026
Sale
Shares
253
Price
$369.48
Total Value
$93.48K
Shares Held After
78,850
% of Holdings
0.3%
Jan 12, 2026
Sale
Shares
584
Price
$368.62
Total Value
$215.27K
Shares Held After
79,103
% of Holdings
0.7%
Version: v26.3.33